These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3556379)

  • 21. Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
    Ferrari E; Fioravanti M; Patti AL; Viola C; Solerte SB
    Pharmatherapeutica; 1987; 5(1):26-39. PubMed ID: 3602021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pentoxifylline and metabolite on red blood cell deformability as measured by ektacytometry.
    Cummings DM; Ballas SK
    Angiology; 1990 Feb; 41(2):118-23. PubMed ID: 2306004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease.
    Angelkort B; Maurin N; Boateng K
    Curr Med Res Opin; 1979; 6(4):255-8. PubMed ID: 527350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Erythrocyte deformability in progressive muscular dystrophy and effect of pentoxifylline].
    Chen SS; Liu JS
    Taiwan Yi Xue Hui Za Zhi; 1986 Mar; 85(3):249-57. PubMed ID: 3462309
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions.
    Leonhardt H; Grigoleit HG
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Sep; 299(2):197-200. PubMed ID: 909613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of pentoxifylline and propentofylline on the turnover of polyphosphoinositides of the erythrocyte membrane and on the metabolism of arachidonic acid in platelets].
    Rossignol L; Plantavid M; Chap H; Douste-Blazy L
    Pathol Biol (Paris); 1988 Oct; 36(8 Pt 2):1073-5. PubMed ID: 2851765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interaction between various alkylxanthines and the proteins of the erythrocyte skeleton].
    Delaunay J; Pothier B; Baklouti F; Morlé L
    Pathol Biol (Paris); 1988 Oct; 36(8 Pt 2):1076-80. PubMed ID: 3065699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of pentoxifylline on the flow properties of human blood.
    Ehrly AM
    Curr Med Res Opin; 1978; 5(8):608-13. PubMed ID: 710175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells.
    Stuart J; Stone PC; Bilto YY; Keidan AJ
    J Clin Pathol; 1987 Oct; 40(10):1182-6. PubMed ID: 3119675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of pentoxifylline on Ca2+-dependent transglutaminase in rat erythrocytes.
    Swislocki NI; Tierney JM
    J Clin Pharmacol; 1989 Sep; 29(9):775-80. PubMed ID: 2572608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of pentoxifylline on impaired red cell deformability following open-heart surgery.
    Koul BL; Nordhas O; Sonnenfeld T; Ekeström S
    Scand J Thorac Cardiovasc Surg; 1984; 18(2):129-31. PubMed ID: 6463626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic retinal vascular complications and erythrocyte filtrability; results of a 2-year follow-up study with pentoxifylline.
    Solerte SB; Ferrari E
    Pharmatherapeutica; 1985; 4(6):341-50. PubMed ID: 4080752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro effects of pentoxifylline on hemoglobin affinity for oxygen and electrolytic equilibrium of human blood.
    Ferraresi I; Bozzini F; Torta D; Frigerio R; Bernasconi C; Agostoni A
    Ric Clin Lab; 1983; 13(4):459-65. PubMed ID: 6658304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and hemorrheologic effects of pentoxifylline in patients with obliterative arteriopathy of the legs].
    Vaya A; Martínez M; Carbonell P; Aznar J
    Angiologia; 1987; 39(6):262-8. PubMed ID: 3425972
    [No Abstract]   [Full Text] [Related]  

  • 35. [Assay of erythrocyte ATP by chemoluminescence. Protective action induced by pentoxifylline on the depletion of energy from stored erythrocytes].
    Acciavatti A; Forconi S; Guerrini M; Pieragalli D; Del Bigo C; Galigani C; Di Perri T
    Ric Clin Lab; 1985; 15 Suppl 1():505-13. PubMed ID: 4035230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the effect of pentoxifylline on the conjunctival microcirculation of diabetic subjects].
    Brancato R; Menchini U; Michelone C
    Ric Clin Lab; 1981; 11 Suppl 1():327-31. PubMed ID: 7188120
    [No Abstract]   [Full Text] [Related]  

  • 37. Decreased fluidity of isolated erythrocyte membranes in type 1 and type 2 diabetes. The effect of resorcylidene aminoguanidine.
    Waczulíkova I; Sikurová L; Cársky J; Strbová L; Krahulec B
    Gen Physiol Biophys; 2000 Dec; 19(4):381-92. PubMed ID: 11409841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study on relationship between erythrocyte filtration and other risk factors in diabetic angiopathy.
    Pozza G; Cordaro C; Carandente O; Margonato A
    Ric Clin Lab; 1981; 11 Suppl 1():317-26. PubMed ID: 7188119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of pentoxifylline on developmental changes in neutrophil cell surface mobility and membrane fluidity.
    Newton JA; Ashwood ER; Yang KD; Augustine NH; Hill HR
    J Cell Physiol; 1989 Sep; 140(3):427-31. PubMed ID: 2550471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pentoxifylline, diltiazem, and A23187: effects on deformability and volume of human red blood cells.
    Dodson RA; Hinds TR; Vincenzi FF
    Proc West Pharmacol Soc; 1988; 31():205-7. PubMed ID: 3145500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.